H. Kantarjian Et Al. , "Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia," NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.9, pp.836-847, 2017
Kantarjian, H. Et Al. 2017. Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia. NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.9 , 836-847.
Kantarjian, H., Stein, A., Goekbuget, N., Fielding, A. K., Schuh, A. C., Ribera, J., ... Wei, A.(2017). Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia. NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.9, 836-847.
Kantarjian, Hagop Et Al. "Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia," NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.9, 836-847, 2017
Kantarjian, Hagop Et Al. "Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia." NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.9, pp.836-847, 2017
Kantarjian, H. Et Al. (2017) . "Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia." NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.9, pp.836-847.
@article{article, author={Hagop Kantarjian Et Al. }, title={Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2017, pages={836-847} }